| Literature DB >> 36068625 |
Lingcai Kong1,2, Mengwei Duan1,2, Jin Shi3, Jie Hong3, Xuan Zhou1,2, Xinyi Yang1,2, Zheng Zhao3, Jiaqi Huang3, Xi Chen3, Yun Yin3, Ke Li3, Yuanhua Liu3, Jinggang Liu1,2, Xiaozhe Wang1,2, Po Zhang1,2, Xiyang Xie1,2, Fei Li4, Zhaorui Chang5, Zhijie Zhang6.
Abstract
BACKGROUND: The continuous mutation of severe acute respiratory syndrome coronavirus 2 has made the coronavirus disease 2019 (COVID-19) pandemic complicated to predict and posed a severe challenge to the Beijing 2022 Winter Olympics and Winter Paralympics held in February and March 2022.Entities:
Keywords: COVID-19; Dynamic model; Prevention and control measure; The Beijing 2022 Winter Olympics
Mesh:
Substances:
Year: 2022 PMID: 36068625 PMCID: PMC9447360 DOI: 10.1186/s40249-022-01019-2
Source DB: PubMed Journal: Infect Dis Poverty ISSN: 2049-9957 Impact factor: 10.485
Fig. 1Compartmental model structure with pulse detection and isolation effect. The blue arrows indicate routine transfer. The red arrows indicate impulse transfer. The dotted line indicates that the patient discharges the virus into the environment and that susceptible people become infected by the virus in the environment. . We consider susceptible (), exposed (), symptomatic infected (), asymptomatic infected (), hospitalized (), recovery (), isolated (, , ) individuals and the virus in the environment (), more details of the model and the transitions between compartments are provided in the text and Table 1
Description of the model compartments
| Compartment | Description |
|---|---|
| Susceptible individuals | |
| Exposed individuals (infected but not infectious) | |
| Asymptomatic infected persons with infectious ability | |
| Symptomatic infected persons with infectious ability | |
| Recovered individuals, get antibodies after recovery | |
| Vaccinated individuals, finished the whole course of COVID-19 vaccination but some did not produce antibodies, still susceptible | |
| Quarantined susceptible individuals, close contacts who are not actually infected and will not be infected during the quarantine period | |
| Quarantined vaccinated individuals, close contacts who are vaccinated and are not actually infected, will not be infected during quarantine | |
| Quarantined exposed individuals, close contacts who are infected but not yet infectious, will be identified through close contact tracing of the infected person and admitted to hospital after testing positive | |
| Hospitalized individuals, infected person (whether asymptomatic or not) admitted to hospital after being detected | |
| Viruses in the environment, excreted by undetected infected individuals, can infect susceptible individuals and vaccinated individuals who have not produced antibodies |
Description of model parameters and their values
| Parameters | Description | Value (range) | Source |
|---|---|---|---|
| Number of contacts of an individual per unit time | 10 (5–20) | [ | |
| The transmission rate of the virus when a susceptible person contacts an infected person | 0.5 (0.4–0.7) | [ | |
| The ratio of susceptibility of vaccinated individuals to symptomatic individuals | 0.8 | Assumed | |
| Effective contact rates of susceptible individuals with viruses in the environment | 0.00414 (0.001–0.01) | [ | |
| The effective protection rate of the vaccine | 68.7% (58.1–76.7%) | [ | |
| Rate of quarantined susceptible individual releasing from quarantine, reciprocal of its average quarantine time | 1/7 | Assumed | |
| Rate of quarantined vaccinated individual releasing from quarantine, reciprocal of its average quarantine time | 1/7 | Assumed | |
| Proportion of infected people with symptoms | 0.8 (0.5–0.9) | China CDC | |
| Reciprocal of the average latent period of symptomatic infections | 1/4.0 (1/4.4–1/3.5) | [ | |
| Reciprocal of the average latent period of asymptomatic infections | 1/4.0 (1/4.4–1/3.5) | [ | |
| The transfer rate of symptomatic infected individuals who were detected and admitted to hospital through health monitoring, reciprocal of the average time from being infectious to detection through health monitoring | 1/2 | Assumed | |
| The transfer rate of quarantined exposed individuals who were detected and admitted to hospital through health monitoring | 1/4 | Assumed | |
| The natural recovery rate of symptomatic infected individuals, the reciprocal of infectious period in symptomatic infected | 1/10 (1/14–1/7) | China CDC | |
| The natural recovery rate of asymptomatic infected individuals, the reciprocal of infectious period in asymptomatic infected | 1/7 (1/10–1/5) | China CDC | |
| Proportion of symptomatic infected persons who were not detected and recovered spontaneously | 0.025 | Assumed | |
| Proportion of asymptomatic infected persons who were not detected and recovered spontaneously | 0.025 | Assumed | |
| The average recovery rate of hospitalized individuals, reciprocal of hospitalization period | 1/14 (1/20–1/10) | China CDC | |
| The rate at which asymptomatic infected individuals shed virus into the environment | 0.05 (0.01–0.1) | [ | |
| The rate at which symptomatic infected individuals shed virus into the environment | 0.1 (0.02–0.2) | [ | |
| Virus mortality in the environment, the reciprocal of the average virus survival time | 1/5 (1/10–1) | [ | |
| Proportion of infected individuals detected by nucleic acid testing | 0.8 | [ | |
| Proportion of exposed individuals detected by nucleic acid testing | 0.4 | Assumed | |
| Number of close contacts per infected individual | 50 | Assumed | |
| Frequency of nucleic acid testing | 3 | Assumed | |
| Probability that close contacts are successfully traced and isolated | 0.9 | [ | |
| Proportion of close contacts who are vaccinated individuals | Determined by the ratio of | ||
| Proportion of close contacts who are susceptible individuals | Determined by the ratio of | ||
| Proportion of close contacts who are exposed individuals | Determined by the ratio of | ||
Fig. 2Simulation results of COVID-19 transmission in scenarios 2 (relax entry measures), scenarios 3 (strict entry measures), and baseline. a Incidence over time; b cumulative cases over time; c prevalence over time; d hospitalized cases. Boxplots represent the mean (dots), median (black line), quarter and third quartile (upper and lower edges of the box), maximum (upper edge) and minimum (lower edge) of hospitalized cases for each scenario
Fig. 3Simulation results of COVID-19 transmission in scenarios 4 (increase contact), scenarios 5 (reduce contact), and baseline. a Incidence over time; b cumulative cases over time; c prevalence over time; d hospitalized cases. Boxplots represent the mean (dots), median (black line), quarter and third quartile (upper and lower edges of the box), maximum (upper edge) and minimum (lower edge) of hospitalized cases for each scenario
Fig. 4Simulation results of COVID-19 transmission in scenarios 6 (high environmental risk), scenarios 7 (low environmental risk), and baseline. a Incidence over time; b cumulative cases over time; c prevalence over time; d hospitalized cases. Boxplots represent the mean (dots), median (black line), quarter and third quartile (upper and lower edges of the box), maximum (upper edge) and minimum (lower edge) of hospitalized cases for each scenario. In figure a–c the simulated curves in the above scenarios basically overlap
Fig. 5Simulation results of COVID-19 transmission in scenarios 8 (cases not detected in time), scenarios 9 (cases detected in time), and baseline. a Incidence over time; b cumulative cases over time; c prevalence over time; d hospitalized cases. Boxplots represent the mean (dots), median (black line), quarter and third quartile (upper and lower edges of the box), maximum (upper edge) and minimum (lower edge) of hospitalized cases for each scenario
Fig. 6Sensitivity analysis of parameters related to contact. a–d Sensitivity analysis of effective contact rate between people; e–h sensitivity analysis of effective contact rate between people and environment; i–l sensitivity analysis of the number of close contacts per infected person. We simulated the incidence, cumulative cases, and prevalence over time and the hospitalized cases when the three parameters increased by 50% and decreased by 50%, and compared them with the baseline levels. The sensitivity analysis curves of the corresponding parameters in figure e, f, g, i, j, k basically overlap
Fig. 7Sensitivity analysis of parameters related to detection of cases. a–d Sensitivity analysis of nucleic acid. testing frequency, we simulated the incidence, cumulative cases, and prevalence over time and the hospitalized cases when the testing frequency was once a day, every two days, every four days, and every five days, and compared them with the baseline level; e–h sensitivity analysis of hospital admission rate through health monitoring for symptomatic infection, we simulated the incidence, cumulative cases, and prevalence over time and the hospitalized cases when the time interval () from the time when a patient was infectious to the time when the patient was found to be infected through health monitoring was 1 day and 3 days, and compared with the baseline level